Welcome to LookChem.com Sign In|Join Free
  • or
5-CYANO-3-PYRIDINYL BORONIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

497147-93-0

Post Buying Request

497147-93-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

497147-93-0 Usage

General Description

5-Cyano-3-pyridinyl boronic acid is a chemical compound that is used as a reagent in organic synthesis and medicinal chemistry. It consists of a pyridine ring with a cyano group and a boronic acid functional group attached. 5-CYANO-3-PYRIDINYL BORONIC ACID is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its ability to form stable complexes with different metal ions. Additionally, it can be used as a building block in the preparation of various heterocyclic compounds, making it a versatile tool for chemical research and drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 497147-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,7,1,4 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 497147-93:
(8*4)+(7*9)+(6*7)+(5*1)+(4*4)+(3*7)+(2*9)+(1*3)=200
200 % 10 = 0
So 497147-93-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H5BN2O2/c8-2-5-1-6(7(10)11)4-9-3-5/h1,3-4,10-11H

497147-93-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Cyano-3-pyridinylboronic acid

1.2 Other means of identification

Product number -
Other names (5-cyanopyridin-3-yl)boronic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:497147-93-0 SDS

497147-93-0Relevant academic research and scientific papers

ORGANIC COMPOUND AND LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE USING THE SAME

-

Paragraph 0300-0303, (2017/08/18)

The present invention relates to an organic compound having excellent hole injection properties and charge generation properties by substituting an electron withdrawing group (Electron acceptor) for a conjugated bipyridine derivative core, to a light-emitting diode applying the organic compound to at least one organic layer, and to a display device.COPYRIGHT KIPO 2017

HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY

-

Page/Page column 187, (2012/01/15)

Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia ( T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

2-AMINOPYRIMIDIN-4-ONES AND THEIR USE FOR TREATING OR PREVENTING Aβ-RELATED PATHOLOGIES

-

Page/Page column 22-23, (2008/06/13)

This invention relates to novel compounds having the structural formula (I) below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds prov

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 497147-93-0